Cardiovascular Dynamics (CVD) expands balloon range
This article was originally published in Clinica
Cardiovascular Dynamics has received US FDA approval to market two more focus angioplasty balloons, the ARC-22 and FACT-22. The newly-approved devices are longer versions (22 mm) of the balloons approved earlier this year. The ARC balloons are designed for stand-alone PTCA while the FACT range is intended for use with other interventional procedures such as stenting and atherectomy.
You may also be interested in...
Dr Reddy’s sees its Indian domestic market and China as hot prospects as it pursues its “transformation journey” in which it is reducing its dependence on the slowing US market.
Glenmark has struck a deal with private equity firm True North for its gynecology business in India and Nepal.